Motivational Interviewing (MI) to Reduce Khat Use (MIkhat)

Evaluation of Motivational Interviewing (MI) to Reduce Khat Use Among Somali Refugees in Kenya

Healthy khat user with the intention to reduce or stop khat use will be randomly assigned to a one-session brief intervention or waiting list. Reductions in khat use will be measured from pre- to post-assessment which will be one month apart. After one month, the waiting list will receive the same intervention.

Study Overview

• Status: Completed
• Conditions: Khat Use Disorder
• Intervention / Treatment: Behavioral: modified ASSIST-linked Brief Intervention

Detailed Description

The leaves of the khat tree are traditionally chewed in some African and Arab countries. They contain the mild central stimulant cathinone. In recent years, the production, trade and use has dramatically increased and excessive patterns of use as well as a specific dependence syndrome have been described. So far, no experiences exist in psychological treatment of khat addiction.

In this study, we use a brief motivational intervention based on the WHO's ASSIST-linked Brief Intervention and Motivational Interviewing to support users who have the intention to reduce or stop their khat use. Khat users will be recruited in the community. Trained local staff will assess participant's khat and other substance use at study entry and one month later. Users will be assigned randomly to intervention or waiting list control groups. The intervention group will receive a single 20-minute brief intervention. The waiting list will receive the same intervention after the second assessment. After two months, a final assessment will be made in both groups.

• Study Type: Interventional
• Enrollment (Anticipated): 200
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Kenya
  • Nairobi, Kenya
    • Tawakal Clinic

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

Healthy individuals

Exclusion Criteria:

Severe psychiatric disorders

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Waiting list; Participants will assessment only during study, same intervention after posttest
Experimental: Intervention; Participants assigned to this arm will receive the modified ASSIST-linked Brief Intervention	Behavioral: modified ASSIST-linked Brief Intervention; Trained counsellors support participant's motivation to reduce or stop khat use in a 20 minute counselling session.; Other Names: Motivational Interviewing

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time-Line-Follow-Back: Self-reported days with khat use and amount of khat use	Participants report in a calender for each day of the past month whether they used khat and how much of it.	one month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time-Line-Follow-Back: other substance use	Participants report for each day of the past month whether they used other substances of abuse, i.e. alcohol, illegal drugs	One month

Collaborators and Investigators

• Sponsor: University of Konstanz
• Collaborators: Africa Mental Health Foundation

Study record dates

Study Major Dates

• Study Start: October 1, 2014
• Primary Completion (Actual): December 1, 2014
• Study Completion (Actual): December 1, 2015

Study Registration Dates

• First Submitted: September 24, 2014
• First Submitted That Met QC Criteria: September 26, 2014
• First Posted (Estimate): October 1, 2014

Study Record Updates

• Last Update Posted (Actual): May 11, 2017
• Last Update Submitted That Met QC Criteria: May 10, 2017
• Last Verified: May 1, 2017

More Information

Terms related to this study

• Other Study ID Numbers: 01DG13020